Back to search

Article

A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patients

2023-04-08

Abstract excerpt

<title>Abstract</title> <p>Purpose: Neoadjuvant treatment (NAT) of early breast cancer is increasingly being used to downstage tumors, allowing improved chances of breast-conserving surgery.Here we combine data from multiple studies to identify pre-treatment and on-treatment biomarkers of response to NAT with the potential to lead to more efficient patient stratification. <h4>Methods:</h4> We pool and analyse 10...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e88fac4c-e645-5627-9fd0-fe292005ab3e
DOI
10.21203/rs.3.rs-2771576/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patientsDOI 10.21203/rs.3.rs-2771576/v1
A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancerSemantic proximity
Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast CancerSemantic proximity
Drug-Gene Network Signature Modeling Predicts Breast Cancer Patient Response to Neoadjuvant ChemotherapySemantic proximity
Gene expression before and after neoadjuvant chemotherapy or endocrine therapy and survival outcomes in hormone receptor-positive, HER2-negative breast cancer: the NEOENDO studySemantic proximity
Integration of multi-omics data shows downregulation of mismatch repair, purin, and tublin pathways in AR-negative triple-negative chemotherapy-resistant breast tumorsSemantic proximity
Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.Semantic proximity
ENDORSE: a prognostic model for endocrine therapy response in advanced estrogen-receptor positive breast cancersSemantic proximity
Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancerSemantic proximity
Prognostic Predictors Do Not Equate to Predictors of Chemotherapy Benefit in HR-Positive, HER2-Negative Breast Cancer: A Population-Based StudySemantic proximity
Identification of a novel gene signature with DDR and EMT difunctionalities for predicting prognosis, immune activity, and drug response in breast cancerSemantic proximity
A six-gene-based signature for breast cancer radiotherapy sensitivity predictionSemantic proximity
Genomic Machine Learning Model Predicts Radiation Therapy Benefit in Early-Stage Breast Cancer Patients with High AccuracySemantic proximity
Select a neighboring publication to make it the new centre.